Rubigo Therapeutics Develops Early Assessment and Treatment for Skin Cancer
The fear of having cancer is not unfounded as the incidence of skin cancer is increasing at an alarming rate due in large part by UV exposure or excessive sun burn.
Month: May 2011
Tianyin Pharmaceuticals Receives China’s SFDA Approval for Its Anti-Diabetic Drug Gliclazide
In 2010, there were 95 million cases of diabetes in China, of which, 52 million and 43 million were found in rural and urban areas, respectively.
Access Pharmaceuticals Inks Deal To Expand MuGard Distribution
Access Pharmaceuticals announced Tuesday it has signed an agreement with eMax Health Systems to expand the distribution of the company’s MuGard treatment.
Valeant Pharmaceuticals to acquire Lithuania’s Sanitas for $442m
Valeant Pharmaceuticals said Tuesday that it agreed to buy Lithuania-based generic drug company Sanitas for €314 million in cash.
Threshold Pharmaceuticals Selectively Targets Tumor Cells in Cancer Therapeutics
Threshold Pharmaceuticals takes advantage of the differences in metabolic activity between cancerous and normal, healthy biological tissue.
BMEYE’s Heart Monitoring Technology May Set A New Standard In Patient Care
During an average life span of 70 years, the human heart will pump more than 400 million litres of blood.
Mystic Pharmaceuticals’ Intranasal Technology Introduces Solutions In Drug Delivery
Delivery of drugs and vaccines via the nose offer many compelling advantages including reduced nausea and toxicity and rapid onset.
Icagen and Pfizer Form Three Way Collaboration with Yale To Explore Chronic Pain Remedies
Chronic pain and epilepsy are debilitating disorders that affect millions of individuals in the US and throughout the world.
June 6 – 9 Jefferies to Host 2011 Global Healthcare Conference
Featuring a Keynote Address from: President Bill Clinton Founder, William J. Clinton Foundation 42nd President of the United States Jefferies, an global securities and investment […]
Wound Management Technologies Addresses Multi Billion Dollar Wound Care Market With CellerateRX
Wound Management’s FDA approved product has become a primary treatment for all types of wounds and sparked interest in the investment community.